Skip to search formSkip to main contentSkip to account menu

EC Regimen (Etoposide-Carboplatin)

Known as: EC Regimen, Etoposide-Carboplatin Regimen 
A regimen consisting of etoposide and carboplatin used for the treatment of extensive-stage small cell lung cancer.
National Institutes of Health

Related topics

Related topics

3 relations
CarboplatinEtoposideSmall cell carcinoma of lung

Search for papers about EC Regimen (Etoposide-Carboplatin)

Search papers
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)